Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Erlander

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Opinion in Drug Discovery & Development|April 3, 2003
Global gene expression analysis of single cellsFredrik Kamme, Mark G Erlander
Molecular Diagnosis & Therapy|November 21, 2009
Molecular classification of cancers of unknown primary siteF Anthony Greco, Mark G Erlander
Seminars in Oncology|January 31, 2009
Molecular classification of unknown primary cancerRichard A Bender, Mark G Erlander
Expert Opinion on Medical Diagnostics|March 14, 2013
Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumorsCatherine A Schnabel, Mark G Erlander
Experimental Hematology & Oncology|August 11, 2016
Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancerDavid Berz, Victoria M Raymond, Jordan H Garst, et al.
Journal of Thoracic Disease|November 30, 2017
Urine test for <i>EGFR</i> analysis in patients with non-small cell lung cancerAleksandra Franovic, Victoria M Raymond, Mark G Erlander, et al.
Journal of Mammary Gland Biology and Neoplasia|February 20, 2004
Laser capture microdissection and advanced molecular analysis of human breast cancerAndrew P Fuller, Darryl Palmer-Toy, Mark G Erlander, et al.
Clinical Colorectal Cancer|October 18, 2011
A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profileJohn D Hainsworth, Catherine A Schnabel, Mark G Erlander, et al.
The Journal of Molecular Diagnostics : JMD|June 29, 2011
Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classificationMark G Erlander, Xiao-Jun Ma, Nicole C Kesty, et al.
The American Journal of Managed Care|October 9, 2014
Health economic analysis of Breast Cancer Index in patients with ER+, LN- breast cancerGary Gustavsen, Brock Schroeder, Patrick Kennedy, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Opinion in Drug Discovery & Development|April 3, 2003
Global gene expression analysis of single cellsFredrik Kamme, Mark G Erlander
Molecular Diagnosis & Therapy|November 21, 2009
Molecular classification of cancers of unknown primary siteF Anthony Greco, Mark G Erlander
Seminars in Oncology|January 31, 2009
Molecular classification of unknown primary cancerRichard A Bender, Mark G Erlander
Expert Opinion on Medical Diagnostics|March 14, 2013
Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumorsCatherine A Schnabel, Mark G Erlander
Experimental Hematology & Oncology|August 11, 2016
Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancerDavid Berz, Victoria M Raymond, Jordan H Garst, et al.
Journal of Thoracic Disease|November 30, 2017
Urine test for <i>EGFR</i> analysis in patients with non-small cell lung cancerAleksandra Franovic, Victoria M Raymond, Mark G Erlander, et al.
Journal of Mammary Gland Biology and Neoplasia|February 20, 2004
Laser capture microdissection and advanced molecular analysis of human breast cancerAndrew P Fuller, Darryl Palmer-Toy, Mark G Erlander, et al.
Clinical Colorectal Cancer|October 18, 2011
A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profileJohn D Hainsworth, Catherine A Schnabel, Mark G Erlander, et al.
The Journal of Molecular Diagnostics : JMD|June 29, 2011
Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classificationMark G Erlander, Xiao-Jun Ma, Nicole C Kesty, et al.
The American Journal of Managed Care|October 9, 2014
Health economic analysis of Breast Cancer Index in patients with ER+, LN- breast cancerGary Gustavsen, Brock Schroeder, Patrick Kennedy, et al.
Pageof 5